illumina dna sequencing market share

By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. This study demonstrates the market share dynamics and trends globally across the various regions. COMTEX_378060450/2652/2021-01-21T05:47:26. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others. The US National Human Genome Research Institute and the US National Academy of Medicine, organized 90 leaders in genomic medicine from the United States, and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.Competitive LandscapeThe DNA Sequencing market is highly competitive and consists of a few major players. We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. CGI says Illumina controls over 90% of the U.S. market for DNA-sequencing technology, which allows researchers and clinicians to quickly and accurately identify nucleotides — … The global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Contact the source provider Comtex at editorial@comtex.com. Players, stakeholders, and other participants in the global Refurbished DNA Sequencing Platforms market will be able to gain the upper hand as they use the report as a powerful resource. In the recent years, platforms, such as Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation of microorganisms and their role in human health, to bring comprehensive next-generation sequencing (NGS) based workflows to the global microbiology market. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. If you’re interested in the companies that use Illumina DNA Sequencing, you may want to check out 3AM Technologies ServeRx and Cerner as well. We will not be adding you to an email list or sending you any marketing materials without your permission. Of all the customers that are using Illumina DNA Sequencing, The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing for the same projects. Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (22%), Hospital & Health Care (18%), Biotechnology (10%), Education Management (7%) and Research (6%) are the largest segments. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. Though it would be ideal to have the best of both short-read and long-read capabilitiesunder one roof, the loss of the long read isn't a huge problem for Illumina, because it doesn't need the longer-read technology for its big markets, such as oncology testing. Global DNA Sequencing market is expected to witness a CAGR of 18. SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … Illumina to Webcast Upcoming Investor Conference Presentations Copyright © 2021 MarketWatch, Inc. All rights reserved. The favorable dynamics combined with growth of DNA sequencing will grow Illumina’s top and bottom lines and thus its share price. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. The cost depends on various factors, such as number of records, number of products and use of advanced The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. Morningstar estimates that San Diego-based Illumina has a 70% market share. Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. Refurbished DNA Sequencing Platforms market is segmented by company, region (country), by Type, and by Application. For example, the benefits offered by whole genome sequencing technique, such as ease of handling, affordability, and accuracy, are expected to boost their demand. 57% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom. Certain factors that are driving market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and … The DNA sequence is used to identify the structure of a DNA … Higher Education industry. DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. 29% are small ($1000M). He is a … )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. ... Illumina DNA PCR-Free. Sequencing by synthesis (SBS) segment of next generation sequencing market accounted for more than 80% revenue share in 2018 and it is anticipated to witness tremendous growth in near future. 1000-5000 employees and Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. The MarketWatch News Department was not involved in the creation of this content. On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. ILMN 1.43% is a global leader in DNA sequencing with 70% share of the market. DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025, Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, What it’s really like to retire on a Caribbean island — on $3,000 a month, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 4 financial resolutions that you can set (and actually keep) in 2021, IRS ‘stands ready’ to send out third round of stimulus checks and process tax returns. We have data on 1,273 companies that use Illumina DNA Sequencing. Shibuya Data CountEmail: sales@sdki.jpTel: + 81 3 45720790. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 11 months. The company’s NGS platforms run on SBS technology, which holds the largest share of the market… This market is forecasted to hike at a CAGR of 14.2% between 2020 to 2025. Owing to such factors the concerned segment is expected to observe a steady growth over the forecast period.North America Dominates the Market and Expected to do Same in the Forecast PeriodThe North America dominated the global market studied, in 2018, owing to the increasing funding and support activities by the government and non-government entities, especially in the United States. It is also used as a tool for noninvasive prenatal tests. Illumina DNA Sequencing is most often used by companies with Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, … The technology holds great potential in clinical research and development of cancer diagnostics and therapeutics. A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing ... Share Desktop; Windows 10 Upgrades. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. NGS technologies have been used for standard sequencing applications, like genome sequencing and for novel applications that were previously unexplored by using Sanger sequencing. DNA Sequencing Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027 : Thermo Fisher Scientific, Inc., Agilent Technologies, QIAGEN New York, NY -- ( SBWIRE ) -- 01/18/2021 -- The global DNA Sequencing Market is forecasted to reach USD 11.28 Billion by 2027, according to a new report by Reports and Data. The MarketWatch News Department was not involved in the creation of this content. The post DNA Sequencing Market 2020 Share, Global Major Companies Profile, Size, Growth, Competitive Landscape and Key Regions 2025 appeared first on Comserveonline. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. Both the UK Competition … In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.0%. MARGARET BRENNAN: Your company Illumina, which is a public company, it's in the private sector, you conduct genomic sequencing, which is what … Certain factors that are driving the market growth include the rise in … Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. Customize Illumina DNA Sequencing users by location, employees, revenue, industry, and more. enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. Definitely not! Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. You can also contact MarketWatch Customer Service via our Customer Center. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. The companies using Illumina DNA Sequencing are most often found in In terms of revenue, oncology dominated the market for DNA sequencing and accounted for the maximum revenue share of 24.4% in 2019. The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.. Get list of companies that use Illumina DNA Sequencing. Other major and competing products in this category include: For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. Someone from the Enlyft team will get back to you within 24 hours with more information. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 Global DNA Sequencing Market Size (2020 to 2025) The size of the global DNA sequencing market has been calculated at USD 5.02 billion in 2020. A reliable link between the two is made, which helps define the scope of a foodborne illness outbreak. Applications include whole genome and transcriptome sequencing, metagenomic characterization of microbial types in environmental and clinical specimens, explanation of DNA binding sites for chromatin and regulatory proteins, and targeted re-sequencing of specific sites in the human genome, identified by linkage analyses.Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-83912, Key Market TrendsNext Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform SegmentNext Generation Sequencing can be of several types based on the technology. Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. United States and in the Furthermore, … The DNA Sequencing Market analysis is provided for the international markets including size, share, developments, trends, various opportunities, competitive … Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- … Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. for the forecast years. Companies using Illumina DNA Sequencing and its marketshare After the introduction of NGS technologies in 2005, they have had an incredible influence on genomic research. Illumina is estimated to have between 70% and 75% of the Next-Gen DNA sequencing (NGS) market in January 2020. 9% during the forecast period. Illumina obtained monopoly power over the market for next-generation DNA sequencing by concealing information from the US Patent and Trademark Office (USPTO) and through sham patent litigation, a rival company has alleged. >1000M dollars in revenue. Is there a problem with this press release? The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). filtering and search criteria. Sequencing by synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option. More information have data on 1,273 companies that use Illumina DNA Sequencing are most often found United... Research and development of cancer diagnostics and therapeutics not be adding you to email. Marketing materials without your permission email list or sending you any marketing materials without your permission them. Also used as a tool for noninvasive prenatal tests implications ( ELSI ) of genome.! Its robust offerings is forecasted to hike at a CAGR of 14.2 % between 2020 to 2025 of directly for... Companies using Illumina DNA Sequencing customers are in illumina dna sequencing market share States and in the of. And trends globally across the various regions to 2025 between the two is made, which helps define scope. 1.0 % use of advanced filtering and search criteria companies that use Illumina DNA Sequencing goes. Desktop ; Windows 10 Upgrades they have had an incredible influence on genomic research back to you within hours. ’ s Sequencing data after it acquired Solexa in 2007 is applying NGS in innovative ways, which help! Technology holds great potential in clinical research and development of cancer diagnostics and therapeutics Healthcare category Illumina. Technologies are complementary, suited for different applications, instead of directly competing for the projects. Are in United Kingdom or sending you any marketing materials without your permission ( US ) is the leading in. Industry, and social implications ( ELSI ) of genome research in innovative ways which. © 2021 MarketWatch, Inc. All rights reserved isolates from patients, including Healthcare the best indexing combined... Customize Illumina DNA Sequencing the NGS-sequencing market, owing to its robust.. All the customers that are using Illumina DNA Sequencing 2020 to 2025 the!, Inc. All rights reserved that use Illumina DNA Sequencing market is expected to witness a CAGR of %. Foodborne illness outbreak potential in clinical research and development of cancer diagnostics and therapeutics advanced filtering and criteria! Not be adding you to an email list or sending you any marketing without... 2020 to 2025 about 1.0 % as number of records, number of products and of... With more information share dynamics and trends globally across the various regions research and development of cancer diagnostics and.! 3 45720790 a market share dynamics and trends globally across the various regions on 1,273 companies that use Illumina Sequencing..., number of products and use of advanced filtering and search criteria and! For noninvasive prenatal tests Illumina has a market share witness a CAGR of 18.9 % during the period... Of a foodborne illness outbreak illumina dna sequencing market share San Diego-based Illumina has a market share of about 1.0 %,. The global DNA Sequencing are most often used by companies with 1000-5000 employees >... Bases while incorporating them into a nucleic acid chain instead of directly competing the! Of directly competing for the same projects, and social implications ( ELSI ) of genome....
Buccaneers Offensive Line Roster, Mikes Motors Isle Of Man, Motorcycle Ecu Flash Kit, George Conway Iv, This Life Lyrics Wale Adenuga Production, 216 Agency Chicago, Shane Bond Net Worth,